Jeuveau is not definitively better than Botox. In clinical trials, the two neurotoxins performed so similarly that no statistically significant difference was found between them in effectiveness, patient satisfaction, or duration of results. Where Jeuveau does have a potential edge is in price (typically 20 to 30% less per unit) and possibly a slightly faster onset. But they are, for most practical purposes, interchangeable treatments for frown lines.
How They Compare in Clinical Trials
A Phase III clinical study directly compared Jeuveau and Botox at the same dose (20 units each) for treating moderate to severe frown lines between the eyebrows. At 14 days post-injection, 92% of Jeuveau patients showed meaningful improvement compared to 90.3% of Botox patients. At 30 days, 92% of Jeuveau patients still showed improvement versus about 84% for Botox. By day 90, the numbers were 64% and 57%, respectively.
Jeuveau showed slightly higher response rates at every time point measured, with an average absolute difference of about 10 percentage points. The most notable gap appeared at day 150 (five months out), when 40% of Jeuveau patients were still showing improvement compared to 19.4% of Botox patients. That sounds dramatic, but none of these differences reached statistical significance, meaning they could easily be explained by chance, especially given the small sample sizes (25 Jeuveau patients and 31 Botox patients). The honest takeaway: both products work well, and neither has proven superiority over the other.
Patient Satisfaction
Satisfaction scores followed the same pattern. By day 14, 88% of Jeuveau patients reported feeling satisfied or very satisfied with their results, compared to 74.2% of Botox patients. More than half of patients in both groups maintained satisfaction throughout the full study period. Again, these differences were not statistically significant, so while the trend favored Jeuveau in this particular trial, it’s not strong enough evidence to call one product clearly better.
Onset and Duration
One area where Jeuveau may have a practical advantage is how quickly it kicks in. Most patients see noticeable results from Jeuveau within two to three days, with full results by day three or four. Botox typically takes a full week or sometimes longer to reach its peak effect. If you have an event coming up and want faster visible results, that difference could matter.
In terms of how long results last, both products perform the same. You can expect three to four months of wrinkle reduction from either one before the effects gradually wear off and you need another treatment.
The Price Difference
Cost is where Jeuveau most clearly separates itself. Botox typically runs between $10 and $20 per unit, while Jeuveau generally costs 20 to 30% less, putting it in the $8 to $16 per unit range. Since a typical frown line treatment uses 20 units, that difference can save you $40 to $80 per session, or roughly $120 to $320 per year if you’re getting treatments every three to four months. Jeuveau was specifically designed and marketed as a cosmetic-only competitor to Botox, and competitive pricing is a core part of that strategy.
What Jeuveau Can and Can’t Treat
This is an important distinction. Botox is FDA-approved for a wide range of uses: frown lines, crow’s feet, forehead lines, chronic migraines, excessive sweating, overactive bladder, and several other medical conditions. Jeuveau has exactly one FDA-approved indication: moderate to severe frown lines (the vertical “11” lines between your eyebrows). It is not approved for any other cosmetic area or any medical condition.
Some providers do use Jeuveau off-label in other facial areas like crow’s feet or forehead lines, but if you’re looking for a neurotoxin to treat anything beyond frown lines, Botox has the broader regulatory track record.
How They Work
Both Jeuveau and Botox are type A botulinum toxins. They work the same way: temporarily blocking the nerve signals that tell muscles to contract, which smooths out the wrinkles caused by repeated muscle movement. Both are injected at the same dosage (20 units for frown lines), and the treatment experience is essentially identical, taking about 10 to 15 minutes in a provider’s office.
One technical note: although both are dosed in “units,” the FDA specifically states that units of Jeuveau cannot be directly compared to or converted into units of Botox, because each product is measured using its own proprietary assay. In practice, providers treat them as roughly equivalent at a 1:1 ratio for frown lines, and clinical trials used matching doses. But they are manufactured through different processes by different companies, so they’re not identical at the molecular level.
Which One Should You Choose
If you only need frown line treatment and want to save money, Jeuveau is a reasonable choice. It performs comparably to Botox in clinical data, may work slightly faster, and costs less per unit. If you want a product with a longer track record (Botox has been on the market since 2002 for cosmetic use, Jeuveau since 2019), or if you need treatment for areas beyond the frown lines, Botox is the more established option. Many providers carry both and can help you decide based on your treatment goals, but you shouldn’t expect a dramatically different result from one versus the other.